[an error occurred while processing this directive]

POSTGRADUATE MEDICINE: JULY-DECEMBER 2001

INDEX TO VOLUME 110

This index is also available as a 26K PDF document

SUBJECTS

AGING

Bone densitometry testing to detect osteoporosis. (CC) 110(6):51
Hyperglycemia, interpretation in elderly patient. (CC) 110(4):15
Pain management in elderly patients. 110(2):109
Parkinson's disease, epidemiology, diagnosis, and management. 110(6):15*

ALLERGY

Contact dermatitis from neomycin sensitivity. (PD) 110(3):37

ASTHMA

As symptom of Churg-Strauss syndrome. (PDQ) 110(5):23

CARDIOVASCULAR DISEASES

Aortic stenosis, risks of intervention in asymptomatic disease. 110(2):28*
As cause of death in patients with end-stage renal disease. 110(3):24
Hypertension, results of trials comparing conventional treatments with angiotensin-converting enzyme inhibitors, calcium channel blockers, and alpha blockers. 110(5):39*
Hypertension syndrome and cardiovascular events. 110(5):29*
Mitral valve prolapse, diagnosis and management. 110(2):43*
Mitral valve regurgitation, diagnosis and management. 110(2):57*
Preventing coronary artery disease through treating lipid disorders in patients with type 2 diabetes. 110(1):111*
Valvular heart disease in pregnancy, causes, clinical findings, and management. 110(2):69*

CHOLESTEROL

Lipid disorders in patients with type 2 diabetes, treatment to reduce cardiovascular risk. 110(1):111*

CHRONOTHERAPEUTICS

Theory and evidence of benefits. 110(2):119*

COMPUTERS

Handheld, online prescribing. (ED) 110(1):9

DELIVERY OF HEALTHCARE

Clinical practice guidelines, disease-specific medical practice protocols developed by Institute for Clinical Systems Improvement. (ED) 110(5):15
Controlling pharmacy costs while delivering quality care. (ED) 110(1):7
Government regulations, drawbacks of mandates. (ED) 110(2):11

DIABETES

Classification, distinction between type 1 and type 2. (CC) 110(2):23
Diabetic ketoacidosis, questions and answers about diagnosis, treatment, and hospitalization issues. 110(5):89*
Type 2, lipid-lowering treatment to reduce cardiovascular risk. 110(1):111*

DIAGNOSTIC IMAGING

Bone scan in diagnosis of stress fractures. 110(3):117
Magnetic resonance imaging and interventional neuroradiology, new techniques for diagnosis and treament of neurologic disorders. 110(3):97*

DIAGNOSTIC TECHNIQUES

Laboratory studies to detect albuminuria, proteinuria. 110(4):82
Noninvasive and invasive tests for screening for H pylori infection. 110(3):78

DRUG FORMULARY

Role in controlling pharmacy costs. (ED) 110(1):9

DRUG THERAPY

For pain management in dying patients. 110(2):99*
For lice, scabies, and chiggers. 110(1):58
For Parkinson's disease. 110(6):18
For posttraumatic stress disorder. 110(5):62
For primary and secondary pain in Parkinson's disease. 110(6):33*
For reducing proteinuria and slowing renal disease progression. 110(4):93
Timing of medications according to chrono-therapeutic principles. 110(2):119*

DRUGS, ADVERSE REACTION

Allergic contact dermatitis from neomycin sensitivity. (PD) 110(3):37
Amiodarone-induced pulmonary toxicity. (PDQ) 110(2):93
To opioids. 110(2):109

DRUGS, ANTIBIOTIC

For methicillin-resistant Staphylococcus aureus infection. 110(4):46
For prophylaxis against endocarditis. 110(2):71
For treatment of staphylococcal toxic shock syndrome. 110(4):61

DRUGS, ANTICOAGULANT

Problems with use in pregnant women with valvular heart disease. 110(2):72

DRUGS, ANTIDEPRESSANT

For posttraumatic stress disorder. 110(5):62

DRUGS, ANTIFUNGAL

Oral and topical, for dermatophyte infections. 110(1):83*

DRUGS, ANTIHYPERTENSIVE

For improving arterial compliance in patients with hypertension. 110(5):33
For lowering blood pressure and reducing risk of cardiovascular events, comparison of agents. 110(5):39*

DRUGS, ANTIMICROBIAL

Triple therapy for eradication of H pylori. 110(3):81

DRUGS, GENERIC

Use, to lower pharmacy costs. (ED) 110(1):8

DRUGS, HISTAMINE₂ BLOCKER

For gastroesophageal reflux disease. 110(3):48

DRUGS, LIPID-LOWERING

For reducing cardiovascular risk in type 2 diabetes. 110(1):117

DRUGS, NONSTEROIDAL ANTI-INFLAMMATORY (NSAIDs)

Cause of gastrointestinal mucosal injury. 110(3):87*

DRUGS, PROTEIN PUMP INHIBITOR

For gastroesophageal reflux disease. 110(3):51

DRUGS, SIDE EFFECTS

NSAID-related gastrointestinal mucosal injury. 110(3):87*

EAR DISEASES

Tympanic membrane perforation in adults, causes, evaluation, and treatment. 110(5):81*

ECHOCARDIOGRAPHY

In assessing aortic stenosis. 110(2):30
In assessing mitral valve regurgitation. 110(2):58
In diagnosing mitral valve prolapse. 110(2):47
Role in management of Staphylococcus aureus bacteremia. 110(4):29

ENDOCRINE DISORDERS

Diabetes: See Diabetes
Hyperglycemia, interpretation in elderly patient. (CC) 110(4):15

ENDOSCOPY

Flexible sigmoidoscopy, common complications, management. (CC) 110(1):127
For screening and surveillance of patients with Barrett's esophagus. 110(3):58
New technologies for treatment of gastroesophageal reflux disease. 110(3):51

EYE DISEASES

Oculodermal melanocytosis (nevus of Ota), diagnosis and treatment. (PP) 110(6):43

FEVER

Febrile seizures. (PN) 110(2):135

GASTROINTESTINAL DISEASES

Barrett's esophagus, incidence, screening recommendations, and management options. 110(3):57*
Gastroesophageal reflux disease, clinical manifestations, diagnosis, and treatment options. 110(3):42*
H pylori infection, pathogenesis, identification, and treatment recommendations. 110(3):71*
Mucosal injury from long-term NSAID use, epidemiology, prevention, and management. 110(3):87*

GENITAL DISEASES

Benign prostatic hyperplasia. (PN) 110(3):125

GERIATRICS: See Aging

HEART DISEASE: See Cardiovascular diseases

HOSPITALS

Nosocomial infections, role of coagulase-negative staphylococci. 110(4):63*

HYPERTENSION: See Cardiovascular diseases

IMMUNIZATION

Routine childhood immunization recommendations. 110(1):68

INFECTION

Coagulase-negative staphylococci, clinical manifestations and virulence factors. 110(4):63*
Fungal, in children, diagnosis and treatment options. 110(1):83*
Methicillin-resistant Staphylococcus aureus, risk factors, diagnosis, and management. 110(4):43*
Staphylococcal toxic shock syndrome, pathogenesis, clinical presentation, treatment, and prevention. 110(4):55*
Staphylococcus aureus, life-threatening manifestations, diagnosis, and treatment. 110(4):24*
Urinary tract infections. (PN) 110(1):135
Zoonotic, from pets, risks and treatment. 110(1):24*

INJURIES: See Trauma

KIDNEY DISEASES

Assessment of kidney function by estimating the glomerular filtration rate. 110(6):55*
Chronic, concerns about increasing incidence and new initiative on evaluation, classification, and stratification. 110(3):23*
Proteinuria as evidence of kidney injury, mechanisms, testing methods, and clinical significance. 110(4):79*
Urinary tract infections. (PN) 110(1):135

LABORATORY INVESTIGATION

Estimation of the glomerular filtration rate to assess kidney function. 110(6):55*

LUNG DISEASES

Pulmonary toxicity, amiodarone-induced. (PDQ) 110(2):93

MEN

Benign prostatic hyperplasia. (PN) 110(3):125

MUSCULOSKELETAL DISORDERS

Osteoporosis, detection through bone densitometry testing. (CC) 110(6):51

NEOPLASMS

Nevus of Ota, malignant transformation. (PP) 110(6):43

NEUROLOGIC MANIFESTATIONS

Central nervous system disorders, using magnetic resonance imaging and interventional neuroradiology in diagnosis and management. 110(3):97*
Parkinson's disease, primary and secondary pain and its treatment. 110(6):33*
Parkinson's disease, treatment principles and practice, new therapeutic approaches. 110(6):15*

OSTEOPOROSIS

Detection through bone densitometry testing. (CC) 110(6):51

PAIN

In Parkinson's disease, approach to treatment. 110(6):33*
Management in dying patients. 110(2):99*
Undertreated, barriers to effective relief. (ED) 110(3):15

PATIENT EDUCATION

Benign prostatic hyperplasia. (PN) 110(3):125
Febrile seizures. (PN) 110(2):135
Posttraumatic stress disorder. (PN) 110(5):97
Urinary tract infections. (PN) 110(1):135

PATIENTS

Concerns about undertreated pain, barriers to and need for effective relief. (ED) 110(3):15

PEDIATRICS

Ectoparasites in children, eradication of lice, scabies, and chiggers. 110(1):57*
Febrile seizures. (PN) 110(2):135
Fungal skin infections in children, diagnosis and treatment options. 110(1):83*
Routine immunization guidelines and other strategies in travelers, immigrants, and international adoptees. 110(1):67*
Zoonotic infections from pets, risks and treatment. 110(1):24*

PHYSICIANS

Concerns about government-mandated medicine. (ED) 110(2):11
Need for a new approach to pain management. (ED) 110(3):15

POSTTRAUMATIC STRESS DISORDER

Causes, symptoms, and management in the primary care setting. 110(5):60*
Information for patients. (PN) 110(5):97

PREVENTIVE MEDICINE

Flexible sigmoidoscopy, common complications, management. (CC) 110(1):127
Precautions in travelers, immigrants, and international adoptees. 110(1):67*
Strategies for preventing stress fractures. 110(3):123

PSYCHIATRIC/PSYCHOSOCIAL DISORDERS

Posttraumatic stress disorder, causes, symptoms, and management in the primary care setting. 110(5):60*

PUBLIC HEALTH

Chronic kidney disease, increasing incidence and mortality rate, quality of care and outcomes. 110(3):23*

PULMONARY DISEASES: See Lung diseases

QUALITY OF HEALTHCARE

Role of Institute for Clinical Systems Improvement in assisting medical groups and hospitals to improve care. (ED) 110(5):15

RADIOGRAPHY

Interventional advances in diagnosis and treatment of central nervous system disorders. 110(3):98

RENAL FAILURE: See Kidney diseases

RESPIRATORY DISEASES

Churg-Strauss syndrome, report of a case. (PDQ) 110(5):23

RISK FACTORS

For cardiovascular disease, by blood pressure status. 110(5):31

SCREENING

For B₁₂ deficiency. 110(1):102

SEIZURES

Febrile seizures. (PN) 110(2):135

SKIN DISEASES

Ectoparasites, eradication of lice, scabies, and chiggers in children. 110(1):57*
Fungal infections in children, diagnosis and treatment options. 110(1):83*
Nevus of Ota, diagnosis and treatment. (PP) 110(6):43
Rash from contact dermatitis, causes and diagnosis. (PD) 110(3):37

SPORTS

Stress fractures, pathogenesis, diagnosis, and treatment. 110(3):115*

STROKE

Role of magnetic resonance imaging and interventional neuroradiology in management. 110(3):98

SURGERY

Antireflux, for gastroesophageal reflux disease. 110(3):51
Antireflux, for resection of adenocarcinoma in Barrett's esophagus. 110(3):65
Repair of mitral valve for regurgitation. 110(2):60
Repair of tympanic membrane perforation in adults. 110(5):83

TOXIC SHOCK SYNDROME

Staphylococcal, pathogenesis, clinical presentation, treatment, and prevention. 110(4):55*

TRAUMA

Acute tympanic membrane perforation in adults. 110(5):81*
Stress fractures, pathogenesis, diagnosis, and treatment. 110(3):115*

TRAVEL MEDICINE

Immunizations and other strategies in international travelers, immigrants, and international adoptees. 110(1):67*

VACCINATION: See Immunization

VITAMINS

B₁₂ deficiency, screening, diagnosis, and treatment. 110(1):99*

WOMEN

Bone densitometry testing to detect osteoporosis. (CC) 110(6):51
Urinary tract infections. (PN) 110(1):135

*Major clinical discussion
CC, Curbside Consults
ED, Editorial
PD, Pearls in Dermatology
PDQ, Pulmonary Diagnostic Quiz
PN, Patient Notes
PP, Puzzles in Practice

AUTHORS

ABRAHM J Pain management for dying patients: How to assess needs and provide pharmacologic relief. 110(2):99

BADDOUR LM Introduction to symposium on staphylococcal infections. 110(4):19

BERG D Fungal skin infections in children: New developments and treatments. 110(1):83

BOHANNON NJV Type 1 versus type 2 diabetes still a useful distinction? (CC) 110(2):23

BRADY WJ See Perron AD

BRAMAN S See Hiranniramol S

CARROLL MF Ten pivotal questions about diabetic ketoacidosis: Answers that clarify new concepts in treatment. 110(5):89

CHAUDHRY B Solving a severe asthma episode. (PDQ) 110(5):23

DAVIS PW Complications of flexible sigmoidoscopy? (CC) 110(1):127

DHARMARAJAN TS Approaches to vitamin B₁₂ deficiency: Early treatment may prevent devastating complications. 110(1):99

DONNELLY NJ See Khouzam HR

EKNOYAN G National epidemic of chronic kidney disease: What we know and what we can do. 110(3):23

ELLIOT WJ Timing treatment to the rhythm of disease: A short course in chronotherapeutics. 110(2):119

ERICKSON P Introduction to symposium on critters and kids. 110(1):15

See also Berg D

FENNERTY MB Introduction to symposium on acid peptic disease. 110(3):41

NSAID-related gastrointestinal injury: Evidence-based approach to a preventable complication. 110(3):87

FLORA K See Kaynard A

GLASSER SP Hypertension syndrome and cardiovascular events: High blood pressure is only one risk factor. 110(5):29

GOPAL DV Another look at Barrett's esophagus: Current thinking on screening and surveillance strategies. 110(3):57

GWINN-HARDY K See Waseem S

HEBERT LA The urgent call of albuminuria/proteinuria: Heeding its significance in early detection of kidney disease. 110(4):79

HERMANOWICZ N Management of Parkinson's disease: Strategies, pitfalls, and future directions. 110(6):15

HIRANNIRAMOL S Cracking a dyspnea mystery. (PDQ) 110(2):93

ISSA NC Staphylococcal toxic shock syndrome: Suspicion and prevention are keys to control. 110(4):55

KAYNARD A Gastroesophageal reflux disease: Control of symptoms, prevention of complications. 110(3):42

KEANE WF See Eknoyan G; Hebert LA

KEATS TA See Perron AD

KEITH MP Persistent localized rash after trauma: Infection or iatrogenic disease? (PD) 110(3):37

KHAN NM How to interpret a sudden elevation in serum glucose level? (CC) 110(4):15

KHOUZAM HR Posttraumatic stress disorder: Safe, effective management in the primary care setting. 110(5):60

KLEEREKOPER M How reliable are bone densitometry results? (CC) 110(6):51

KNIGGE KL The role of H pylori in gastrointestinal disease: A guide to identification and eradication. 110(3):71

LEVEY AS See Eknoyan G; Manjunath G

LEVIN NW See Eknoyan G

LUNDY LB See Ott MC

MANJUNATH G Estimating the glomerular filtration rate: Dos and don'ts for assessing kidney function. 110(6):55

MARCUS AO Lipid disorders in patients with type 2 diabetes: Meeting the challenges of early, aggressive treatment. 110(1):111

MEHRA MR Introduction to symposium on valvular heart disease. 110(2):27

MISHRIKI YY Are these pigmentary changes only cosmetic? (PP) 110(6):43

MORRISON G Zoonotic infections from pets: Understanding the risks and treatment. 110(1):24

MOSSER G Statewide consortium grapples with "quality care" issues: Minnesota sets the stage for consistent use of best medical practices. (ED) 110(5):15

MULUMUDI MS Mysteries of mitral valve prolapse: Proper treatment requires consideration of all clues. 110(2):43

NAUL LG Optimizing the latest neuroradiology tools: New techniques are particularly useful in stroke management. 110(3):97

NORKUS EP See Dharmarajan TS

O'BRIEN A See Chaudhry B; Hiranniramol S

OLSON-GAREWAL JK Making sense of outpatient pharmacy management: How to control pharmacy costs while delivering quality care. (ED) 110(1):7

OTT MC Tympanic membrane perforation in adults: How to manage, when to refer. 110(5):81

PARK MH Timely intervention in asymptomatic aortic stenosis: Emerging clinical parameters may help predict outcomes. 110(2):28

PERRON AD Principles of stress fracture management: The why and hows of an increasingly common injury. 110(3):115

PETERS G See von Eiff C

PETERSEN K Preparing to meet foreign bugs: Travel, immigration, and international adoptions require special precautions. 110(1):67

POTTS J Eradication of ectoparasites in children: How to treat infestations of lice, scabies, and chiggers. 110(1):57

PRASAD AK Valvular heart disease and pregnancy: A high index of suspicion is important to reduce risks. 110(2):69

PROCTOR RA See von Eiff C

RICH BA Prioritizing pain management in patient care: Has the time come for a new approach? (ED) 110(3):15

SANTIAGO JM See Naul LG

SARNAK MJ See Manjunath G

SCHADE DS See Carroll MF

SCOTT RL Native mitral valve regurgitation: Proactive management can improve outlook. 110(2):57

SETNESS PA Benign prostatic hyperplasia. (PN) 110(3):125

Febrile seizures. (PN) 110(2):135

Introduction to symposium on hypertension. 110(5):26

Introduction to symposium on Parkinson's disease. 110(6):12

Legislating health: Are government regulations the key to ensuring the delivery of quality care? (ED) 110(2):11

Posttraumatic stress disorder. (PN) 110(5):97

Urinary tract infections. (PN) 110(1):135

SIMOR AE Containing methicillin-resistant S aureus: Surveillance, control, and treatment methods. 110(4):43

SPETIE DN See Hebert LA

SPOONER K See Keith MP

THOMPSON RL See Issa NC

VENTURA HO See Prasad AK

VIVEKANANTHAN K See Mulumudi MS

VON EIFF C Coagulase-negative staphylococci: Pathogens have major role in nosocomial infections. 110(4):63

WASEEM S Pain in Parkinson's disease: Common yet seldom recognized symptom is treatable. 110(6):33

WEEMS JJ Jr The many faces of Staphylococcus aureus infection: Recognizing and managing its life-threatening manifestations. 110(4):24

YEUN JY Initial antihypertensive therapy: What are the current drugs of choice? 110(5):39

RETURN TO BACK ISSUES INDEX

[an error occurred while processing this directive]

Please send technical questions related to the Web site to Ann Harste